{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:53:10Z","timestamp":1790218390879,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24890255"],"award-info":[{"award-number":["24890255"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K18935"],"award-info":[{"award-number":["15K18935"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19590081"],"award-info":[{"award-number":["19590081"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22590073"],"award-info":[{"award-number":["22590073"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23229004"],"award-info":[{"award-number":["23229004"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26670241"],"award-info":[{"award-number":["26670241"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Promotion and Mutual Aid Corporation for Private Schools of Japan"},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13104-017-2380-8","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T13:25:22Z","timestamp":1485437122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Attachment of class B CpG ODN onto DOTAP\/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-9587","authenticated-orcid":false,"given":"Rui","family":"Tada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kunisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"issue":"5","key":"2380_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1086\/319235","volume":"32","author":"AS Fauci","year":"2001","unstructured":"Fauci AS. Infectious diseases: considerations for the 21st century. Clin Infect Dis. 2001;32(5):675\u201385.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2380_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3201\/eid1104.041167","volume":"11","author":"AS Fauci","year":"2005","unstructured":"Fauci AS, Touchette NA, Folkers GK. Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases. Emerg Infect Dis. 2005;11(4):519\u201325.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"2380_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11095-009-0011-3","volume":"27","author":"O Borges","year":"2010","unstructured":"Borges O, Lebre F, Bento D, Borchard G, Junginger HE. Mucosal vaccines: recent progress in understanding the natural barriers. Pharm Res. 2010;27(2):211\u201323.","journal-title":"Pharm Res"},{"issue":"4 Suppl","key":"2380_CR4","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/nm1213","volume":"11","author":"J Holmgren","year":"2005","unstructured":"Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med. 2005;11(4 Suppl):S45\u201353.","journal-title":"Nat Med"},{"issue":"5","key":"2380_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1248\/yakushi.14-00006-F","volume":"134","author":"M Kondoh","year":"2014","unstructured":"Kondoh M, Kunisawa J. The cutting edge of epithelium-targeted drug development. Yakugaku Zasshi. 2014;134(5):613.","journal-title":"Yakugaku Zasshi"},{"issue":"6","key":"2380_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2174\/1566524054863924","volume":"5","author":"J Kunisawa","year":"2005","unstructured":"Kunisawa J, Fukuyama S, Kiyono H. Mucosa-associated lymphoid tissues in the aerodigestive tract: their shared and divergent traits and their importance to the orchestration of the mucosal immune system. Curr Mol Med. 2005;5(6):557\u201372.","journal-title":"Curr Mol Med"},{"issue":"2","key":"2380_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1248\/yakushi.127.319","volume":"127","author":"J Kunisawa","year":"2007","unstructured":"Kunisawa J, Gohda M, Kiyono H. Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine. Yakugaku Zasshi. 2007;127(2):319\u201326.","journal-title":"Yakugaku Zasshi"},{"issue":"2","key":"2380_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","author":"MR Neutra","year":"2006","unstructured":"Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol. 2006;6(2):148\u201358.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2380_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1248\/yakushi.14-00006-3","volume":"134","author":"H Suzuki","year":"2014","unstructured":"Suzuki H, Kondoh M, Yagi K, Kiyono H, Kunisawa J. The development of mucosal vaccine using bacterial function for targeting mucosal tissues. Yakugaku Zasshi. 2014;134(5):629\u201334.","journal-title":"Yakugaku Zasshi"},{"issue":"14","key":"2380_CR10","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1056\/NEJMra011223","volume":"345","author":"G Ada","year":"2001","unstructured":"Ada G. Vaccines and vaccination. N Engl J Med. 2001;345(14):1042\u201353.","journal-title":"N Engl J Med"},{"issue":"2","key":"2380_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1586\/14760584.2.2.205","volume":"2","author":"J Holmgren","year":"2003","unstructured":"Holmgren J, Harandi AM, Czerkinsky C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev Vaccines. 2003;2(2):205\u201317.","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"2380_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/1568026043451230","volume":"4","author":"A Plant","year":"2004","unstructured":"Plant A, Williams NA. Modulation of the immune response by the cholera-like enterotoxins. Curr Top Med Chem. 2004;4(5):509\u201319.","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"2380_CR13","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1189\/jlb.0604330","volume":"77","author":"D Alignani","year":"2005","unstructured":"Alignani D, Maletto B, Liscovsky M, Ropolo A, Moron G, Pistoresi-Palencia MC. Orally administered OVA\/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. J Leukoc Biol. 2005;77(6):898\u2013905.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"2380_CR14","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","volume":"186","author":"RS Chu","year":"1997","unstructured":"Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med. 1997;186(10):1623\u201331.","journal-title":"J Exp Med"},{"issue":"13","key":"2380_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.ijpara.2005.08.010","volume":"35","author":"HM Hernandez","year":"2005","unstructured":"Hernandez HM, Figueredo M, Garrido N, Sanchez L, Sarracent J. Intranasal immunisation with a 62\u00a0kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice. Int J Parasitol. 2005;35(13):1333\u20137.","journal-title":"Int J Parasitol"},{"issue":"9","key":"2380_CR16","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.4049\/jimmunol.161.9.4463","volume":"161","author":"MJ McCluskie","year":"1998","unstructured":"McCluskie MJ, Davis HL. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol. 1998;161(9):4463\u20136.","journal-title":"J Immunol"},{"issue":"10","key":"2380_CR17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/BF03401824","volume":"6","author":"MJ McCluskie","year":"2000","unstructured":"McCluskie MJ, Weeratna RD, Davis HL. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution. Mol Med. 2000;6(10):867\u201377.","journal-title":"Mol Med"},{"issue":"7\u20138","key":"2380_CR18","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S0264-410X(00)00215-2","volume":"19","author":"MJ McCluskie","year":"2000","unstructured":"McCluskie MJ, Weeratna RD, Krieg AM, Davis HL. CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine. 2000;19(7\u20138):950\u20137.","journal-title":"Vaccine"},{"issue":"3","key":"2380_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.addr.2008.12.008","volume":"61","author":"J Vollmer","year":"2009","unstructured":"Vollmer J, Krieg AM. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev. 2009;61(3):195\u2013204.","journal-title":"Adv Drug Deliv Rev"},{"issue":"45","key":"2380_CR20","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.1016\/j.vaccine.2005.06.024","volume":"23","author":"RD Weeratna","year":"2005","unstructured":"Weeratna RD, Makinen SR, McCluskie MJ, Davis HL. TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848). Vaccine. 2005;23(45):5263\u201370.","journal-title":"Vaccine"},{"issue":"1","key":"2380_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0167-4781(99)00140-2","volume":"1489","author":"AA Levin","year":"1999","unstructured":"Levin AA. A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochim Biophys Acta. 1999;1489(1):69\u201384.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2380_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1385\/IR:24:3:225","volume":"24","author":"BS McKenzie","year":"2001","unstructured":"McKenzie BS, Corbett AJ, Brady JL, Dyer CM, Strugnell RA, Kent SJ, Kramer DR, Boyle JS, Lew AM. Nucleic acid vaccines: tasks and tactics. Immunol Res. 2001;24(3):225\u201344.","journal-title":"Immunol Res"},{"key":"2380_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1472-6750-11-88","volume":"11","author":"W Meng","year":"2011","unstructured":"Meng W, Yamazaki T, Nishida Y, Hanagata N. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists. BMC Biotechnol. 2011;11:88.","journal-title":"BMC Biotechnol"},{"issue":"3","key":"2380_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.addr.2008.12.014","volume":"61","author":"KD Wilson","year":"2009","unstructured":"Wilson KD, de Jong SD, Tam YK. Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy. Adv Drug Deliv Rev. 2009;61(3):233\u201342.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2380_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2008.01.013","volume":"28","author":"T Haas","year":"2008","unstructured":"Haas T, Metzger J, Schmitz F, Heit A, Muller T, Latz E, Wagner H. The DNA sugar backbone 2\u2032 deoxyribose determines toll-like receptor 9 activation. Immunity. 2008;28(3):315\u201323.","journal-title":"Immunity"},{"issue":"4","key":"2380_CR26","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.4049\/jimmunol.162.4.2368","volume":"162","author":"T Sparwasser","year":"1999","unstructured":"Sparwasser T, Hultner L, Koch ES, Luz A, Lipford GB, Wagner H. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. J Immunol. 1999;162(4):2368\u201374.","journal-title":"J Immunol"},{"issue":"2","key":"2380_CR27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0022-3565(24)36667-4","volume":"281","author":"SP Henry","year":"1997","unstructured":"Henry SP, Giclas PC, Leeds J, Pangburn M, Auletta C, Levin AA, Kornbrust DJ. Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action. J Pharmacol Exp Ther. 1997;281(2):810\u20136.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2380_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1525-1470.1996.tb01178.x","volume":"13","author":"Kanwar AJ Nagaraja","year":"1996","unstructured":"Nagaraja Kanwar AJ, Dhar S, Singh S. Frequency and significance of minor clinical features in various age-related subgroups of atopic dermatitis in children. Pediatr Dermatol. 1996;13(1):10\u20133.","journal-title":"Pediatr Dermatol"},{"issue":"10","key":"2380_CR29","doi-asserted-by":"publisher","first-page":"e0139785","DOI":"10.1371\/journal.pone.0139785","volume":"10","author":"R Tada","year":"2015","unstructured":"Tada R, Hidaka A, Iwase N, Takahashi S, Yamakita Y, Iwata T, Muto S, Sato E, Takayama N, Honjo E, et al. Intranasal immunization with DOTAP cationic liposomes combined with DC-cholesterol induces potent antigen-specific mucosal and systemic immune responses in mice. PLoS ONE. 2015;10(10):e0139785.","journal-title":"PLoS ONE"},{"issue":"3","key":"2380_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jconrel.2005.12.016","volume":"111","author":"T Yoshida","year":"2006","unstructured":"Yoshida T, Oide N, Sakamoto T, Yotsumoto S, Negishi Y, Tsuchiya S, Aramaki Y. Induction of cancer cell-specific apoptosis by folate-labeled cationic liposomes. J Control Release. 2006;111(3):325\u201332.","journal-title":"J Control Release"},{"issue":"5","key":"2380_CR31","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1128\/IAI.00240-13","volume":"81","author":"IG Kong","year":"2013","unstructured":"Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, et al. Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae. Infect Immun. 2013;81(5):1625\u201334.","journal-title":"Infect Immun"},{"issue":"5","key":"2380_CR32","doi-asserted-by":"publisher","first-page":"e0126352","DOI":"10.1371\/journal.pone.0126352","volume":"10","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Watari A, Hashimoto E, Yonemitsu M, Kiyono H, Yagi K, Kondoh M, Kunisawa J. C-Terminal Clostridium perfringens enterotoxin-mediated antigen delivery for nasal pneumococcal vaccine. PLoS ONE. 2015;10(5):e0126352.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"2380_CR33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","volume":"1510","author":"SC Semple","year":"2001","unstructured":"Semple SC, Klimuk SK, Harasym TO, Dos Santos N, Ansell SM, Wong KF, Maurer N, Stark H, Cullis PR, Hope MJ, et al. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim Biophys Acta. 2001;1510(1\u20132):152\u201366.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2380_CR34","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.intimp.2007.04.002","volume":"7","author":"KD Wilson","year":"2007","unstructured":"Wilson KD, Raney SG, Sekirov L, Chikh G, deJong SD, Cullis PR, Tam YK. Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles. Int Immunopharmacol. 2007;7(8):1064\u201375.","journal-title":"Int Immunopharmacol"},{"issue":"35","key":"2380_CR35","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1016\/j.biomaterials.2007.08.015","volume":"28","author":"V Kanchan","year":"2007","unstructured":"Kanchan V, Panda AK. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials. 2007;28(35):5344\u201357.","journal-title":"Biomaterials"},{"key":"2380_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1146\/annurev.immunol.18.1.709","volume":"18","author":"B Heyman","year":"2000","unstructured":"Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol. 2000;18:709\u201337.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2380_CR37","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1271\/bbb.80860","volume":"73","author":"R Tada","year":"2009","unstructured":"Tada R, Tanioka A, Ishibashi K, Adachi Y, Tsubaki K, Ohno N. Involvement of branched units at position 6 in the reactivity of a unique variety of \u03b2-d-glucan from Aureobasidium pullulans to antibodies in human sera. Biosci Biotechnol Biochem. 2009;73(4):908\u201311.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"2380_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0163-4453(97)90929-4","volume":"35","author":"B Flehmig","year":"1997","unstructured":"Flehmig B, Staedele H, Xueref C, Vidor E, Zuckerman J, Zuckerman A. Early appearance of neutralizing antibodies after vaccination with an inactivated hepatitis A vaccine. J Infect. 1997;35(1):37\u201340.","journal-title":"J Infect"},{"key":"2380_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1034\/j.1600-065X.2003.00058.x","volume":"194","author":"IC MacLennan","year":"2003","unstructured":"MacLennan IC, Toellner KM, Cunningham AF, Serre K, Sze DM, Zuniga E, Cook MC, Vinuesa CG. Extrafollicular antibody responses. Immunol Rev. 2003;194:8\u201318.","journal-title":"Immunol Rev"},{"issue":"8","key":"2380_CR40","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ni1223","volume":"6","author":"G Napolitani","year":"2005","unstructured":"Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005;6(8):769\u201376.","journal-title":"Nat Immunol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-017-2380-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T20:15:08Z","timestamp":1749932108000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-017-2380-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2380"],"URL":"https:\/\/doi.org\/10.1186\/s13104-017-2380-8","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]},"assertion":[{"value":"21 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"68"}}